Literature DB >> 25492833

Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.

Shia T Kent1, Daichi Shimbo2, Lei Huang3, Keith M Diaz2, Anthony J Viera4, Meredith Kilgore5, Suzanne Oparil6, Paul Muntner3.   

Abstract

Ambulatory blood pressure monitoring (ABPM) can be used to identify white coat hypertension and guide hypertensive treatment. We determined the percentage of ABPM claims submitted between 2007 and 2010 that were reimbursed. Among 1970 Medicare beneficiaries with submitted claims, ABPM was reimbursed for 93.8% of claims that had an International Classification of Diseases, Ninth Revision, diagnosis code of 796.2 ("elevated blood pressure reading without diagnosis of hypertension") versus 28.5% of claims without this code. Among claims without an International Classification of Diseases, Ninth Revision, diagnosis code of 796.2 listed, those for the component (eg, recording, scanning analysis, physician review, reporting) versus full ABPM procedures and performed by institutional versus non-institutional providers were each more than two times as likely to be successfully reimbursed. Of the claims reimbursed, the median payment was $52.01 (25th-75th percentiles, $32.95-$64.98). In conclusion, educating providers on the ABPM claims reimbursement process and evaluation of Medicare reimbursement may increase the appropriate use of ABPM and improve patient care.
Copyright © 2014 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health services; health insurance reimbursement; medicare; white coat hypertension

Mesh:

Year:  2014        PMID: 25492833      PMCID: PMC4262764          DOI: 10.1016/j.jash.2014.09.020

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  29 in total

1.  Hospital characteristics related to the intention to apply for meaningful use incentive payments.

Authors:  Mark L Diana; Abby Swanson Kazley; Eric W Ford; Nir Menachemi
Journal:  Perspect Health Inf Manag       Date:  2012-04-01

2.  European Society of Hypertension position paper on ambulatory blood pressure monitoring.

Authors:  Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2013-09       Impact factor: 4.844

Review 3.  Ambulatory blood-pressure monitoring.

Authors:  Thomas G Pickering; Daichi Shimbo; Donald Haas
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

4.  Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators.

Authors:  J A Staessen; G Byttebier; F Buntinx; H Celis; E T O'Brien; R Fagard
Journal:  JAMA       Date:  1997-10-01       Impact factor: 56.272

5.  Cost-effectiveness of ambulatory blood pressure: a reanalysis.

Authors:  Lawrence R Krakoff
Journal:  Hypertension       Date:  2005-12-12       Impact factor: 10.190

6.  Management of hypertension: summary of NICE guidance.

Authors:  Taryn Krause; Kate Lovibond; Mark Caulfield; Terry McCormack; Bryan Williams
Journal:  BMJ       Date:  2011-08-25

7.  Measuring diagnoses: ICD code accuracy.

Authors:  Kimberly J O'Malley; Karon F Cook; Matt D Price; Kimberly Raiford Wildes; John F Hurdle; Carol M Ashton
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

8.  Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.

Authors:  David J Graham; Rita Ouellet-Hellstrom; Thomas E MaCurdy; Farzana Ali; Christopher Sholley; Christopher Worrall; Jeffrey A Kelman
Journal:  JAMA       Date:  2010-06-28       Impact factor: 56.272

9.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

10.  Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.

Authors:  George S Stergiou; Kei Asayama; Lutgarde Thijs; Anastasios Kollias; Teemu J Niiranen; Atsushi Hozawa; José Boggia; Jouni K Johansson; Takayoshi Ohkubo; Ichiro Tsuji; Antti M Jula; Yutaka Imai; Jan A Staessen
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

View more
  18 in total

1.  Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication.

Authors:  Daichi Shimbo; C Barrett Bowling; Emily B Levitan; Luqin Deng; John J Sim; Lei Huang; Kristi Reynolds; Paul Muntner
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-05-10

2.  Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States.

Authors:  Ian M Kronish; Shia Kent; Nathalie Moise; Daichi Shimbo; Monika M Safford; Robert E Kynerd; Ronan O'Beirne; Alexandra Sullivan; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2017-07-06

Review 3.  Practical Aspects of Home and Ambulatory Blood Pressure Monitoring.

Authors:  Aldo J Peixoto
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

4.  Insights in Public Health: Ambulatory Blood Pressure Monitoring: Underuse in Clinical Practice in Hawai'i.

Authors:  Deborah Taira; Tetine Sentell; Cheryl Albright; Doug Lansidell; Kazuma Nakagawa; Todd Seto; Joel Mark Stevens
Journal:  Hawaii J Med Public Health       Date:  2017-11

Review 5.  Implementing ABPM into Clinical Practice.

Authors:  Alan L Hinderliter; Raven A Voora; Anthony J Viera
Journal:  Curr Hypertens Rep       Date:  2018-02-05       Impact factor: 5.369

6.  Home Blood Pressure Monitoring in Cases of Clinical Uncertainty to Differentiate Appropriate Inaction From Therapeutic Inertia.

Authors:  Sonal J Patil; Nuha K Wareg; Kelvin L Hodges; Jamie B Smith; Mark S Kaiser; Michael L LeFevre
Journal:  Ann Fam Med       Date:  2020-01       Impact factor: 5.166

7.  Masked Hypertension: Fragile in More Ways Than One.

Authors:  Jordana B Cohen
Journal:  Hypertension       Date:  2020-09-09       Impact factor: 10.190

Review 8.  Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

Review 9.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

10.  Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals.

Authors:  Yuichiro Yano; Rikki M Tanner; Swati Sakhuja; Byron C Jaeger; John N Booth; Marwah Abdalla; Daniel Pugliese; Samantha R Seals; Gbenga Ogedegbe; Daniel W Jones; Paul Muntner; Daichi Shimbo
Journal:  JAMA Cardiol       Date:  2019-09-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.